Home / Investor / Press Release / Wockhardt receives QIDP designation for its new Drug WCK 4873 from U.S. FDA
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.